CEACAM1 and cancer: Importantly, patient-derived melanoma infiltrating lymphocytes [64] and circulating T and NK cells from melanoma patients [68] synthesize and express functional CEACAM1 [64, 68, 69, 74], which renders them susceptible to CEACAM1-mediated inhibition and may thus contribute to cancer progression.